Skip to main content
logo
HCW Biologics Inc. (HCWB)
NASDAQ: HCWB · Real-Time Price · USD
3.430
+0.260 (8.20%)
At close: Aug 28, 2026, 4:00 PM EDT
3.300
-0.130 (-3.79%)
After-hours: Aug 28, 2026, 7:38 PM EDT

HCW Biologics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-5.58-7.96-30.02-24.99-14.9-12.86
Depreciation & Amortization
0.61.041.181.140.720.54
Asset Writedown & Restructuring Costs
1.51.5----
Loss (Gain) From Sale of Investments
2.020.27--0.260.190.07
Stock-Based Compensation
0.230.771.0111.120.36
Provision & Write-off of Bad Debts
---5.25--
Other Operating Activities
-8.46-6.23-0-00-0.54
Change in Accounts Receivable
00.550.95-1.12-0.282.37
Change in Accounts Payable
-2.82-3.4711.871.620.421.89
Change in Other Net Operating Assets
0.030.140.78-5.142.35-2.8
Operating Cash Flow
-12.14-13.39-14.23-22.51-10.39-10.98
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
---0.26-6.2-10.28-0.05
Investment in Securities
---1024.98-34.97
Investing Cash Flow
---0.263.814.71-35.02

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-0.156.91-6.45-
Total Debt Issued
-0.156.91-6.45-
Long-Term Debt Repaid
--0.13-0.12-0.04--
Net Debt Issued (Repaid)
-0.360.026.79-0.046.45-
Issuance of Common Stock
8.248.036.460.020.0256.03
Other Financing Activities
2.562.612.32--0.19-6.76
Financing Cash Flow
10.4410.6715.57-0.016.2749.27

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-1.7-2.721.08-18.7310.63.27

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-12.14-13.39-14.49-28.72-20.66-11.02
Free Cash Flow Growth
------
Free Cash Flow Margin
-180.58%-24693.20%-564.48%-1010.51%-307.36%-
Free Cash Flow Per Share
-15.41-38.30-89.64-191.82-138.43-140.94
Levered Free Cash Flow
-11.66-15.630.42-15.29-15.73-5.68
Unlevered Free Cash Flow
-11.32-15.10.83-15.12-15.65-5.68

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
0.470.60.570.280.13-
Change in Working Capital
-2.44-2.7813.6-4.642.491.46
SEC Filings: 10-K · 10-Q